Avant Diagnostics, Inc
company.status.inactiveCIK 1451929fmd_1CAS31MWE6YVRK2N6J4FP35B6KServices · Services-Medical LaboratoriesTemplate: Standard
Coverage: Nov 01, 2008 to Dec 31, 2018, 41 periods
Latest annual · FY2017
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (2)
- Net income
- (2)
- Free cash flow
- (3)
Latest quarter · Q1 FY2019
Millions- Operating income
- (1)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2015 to FY2017
- n/m
- Net income, 5 yearsFY2014 to FY2018
- n/m
Avant Diagnostics, Inc financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2018 | FY2017 | Change | Source |
|---|---|---|---|---|
| Operating income | -$2.3 million | -$8.3 million | 10-K 2019-03-01 · proof | |
| Net income | -$2.4 million | -$9.6 million | 10-K 2019-03-01 · proof | |
| Cash from operating activities | -$3 million | $322,171 | -1,039.2% | 10-K 2019-03-01 · proof |
| Free cash flow | -$3.2 million | 10-K 2019-03-01 · proof | ||
| Total assets | $4.8 million | $5.2 million | -7.9% | 10-K 2019-03-01 · proof |
| Total liabilities | $2.7 million | $4.3 million | -35.4% | 10-K 2019-03-01 · proof |
| Cash and cash equivalents | $30,896 | $1,348 | +2,192% | 10-K 2019-03-01 · proof |
- What was Avant Diagnostics, Inc's operating income in fiscal 2018?
- Avant Diagnostics, Inc reported operating income of -$2.3 million for fiscal 2018 (the year ended Sep 30, 2018), against -$8.3 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2019. SEC
- What was Avant Diagnostics, Inc's net income in fiscal 2018?
- Avant Diagnostics, Inc reported net income of -$2.4 million for fiscal 2018 (the year ended Sep 30, 2018), against -$9.6 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2019. SEC
- What was Avant Diagnostics, Inc's cash from operating activities in fiscal 2018?
- Avant Diagnostics, Inc reported cash from operating activities of -$3 million for fiscal 2018 (the year ended Sep 30, 2018), against $322,171 the year before (-1,039.2%). Source: the 10-K filed with the SEC on Mar 1, 2019. SEC
- What was Avant Diagnostics, Inc's free cash flow in fiscal 2018?
- Avant Diagnostics, Inc reported free cash flow of -$3.2 million for fiscal 2018 (the year ended Sep 30, 2018). Source: the 10-K filed with the SEC on Mar 1, 2019. SEC
- What are Avant Diagnostics, Inc's total assets?
- As of Sep 30, 2018, Avant Diagnostics, Inc reported total assets of $4.8 million, against $5.2 million a year earlier (-7.9%). Source: the 10-K filed with the SEC on Mar 1, 2019. SEC
- What are Avant Diagnostics, Inc's total liabilities?
- As of Sep 30, 2018, Avant Diagnostics, Inc reported total liabilities of $2.7 million, against $4.3 million a year earlier (-35.4%). Source: the 10-K filed with the SEC on Mar 1, 2019. SEC
- What are Avant Diagnostics, Inc's cash and cash equivalents?
- As of Sep 30, 2018, Avant Diagnostics, Inc reported cash and cash equivalents of $30,896, against $1,348 a year earlier (+2,192%). Source: the 10-K filed with the SEC on Mar 1, 2019. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1451929&period_type=annual&limit=5"Information only, not investment advice.